These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 30442055

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding.
    Kim HS, Hwang KY, Chung IK, Park SH, Lee MH, Kim SJ, Hong SY.
    J Korean Med Sci; 2003 Feb; 18(1):58-64. PubMed ID: 12589088
    [Abstract] [Full Text] [Related]

  • 5. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N, Ghazouani L, Saidi S, Ben-Hadj-Khalifa S, Addad F, Almawi WY, Mahjoub T.
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.
    Gong LL, Peng JH, Han FF, Zhu J, Fang LH, Wang YH, Du GH, Wang HY, Liu LH.
    Thromb Res; 2012 Sep; 130(3):e43-51. PubMed ID: 22771216
    [Abstract] [Full Text] [Related]

  • 8. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY.
    J Stroke Cerebrovasc Dis; 2007 Sep; 16(4):153-9. PubMed ID: 17689411
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and primary open-angle glaucoma.
    Mossböck G, Weger M, Faschinger C, Schmut O, Renner W.
    Mol Vis; 2008 Jul 04; 14():1240-4. PubMed ID: 18615155
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
    Espino A, Villagrán A, Vollrath V, Hanckes P, Salas R, Farah A, Solís N, Pizarro M, Escalona A, Boza C, Pérez G, Carrasco G, Padilla O, Miquel JF, Nervi F, Chavez-Tapia NC, Arab JP, Alvarez-Lobos M, Arrese M, Riquelme A.
    Ann Hepatol; 2011 Jul 04; 10(4):493-501. PubMed ID: 21911891
    [Abstract] [Full Text] [Related]

  • 13. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec 04; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 14. Fibrinolytic gene polymorphism and ischemic stroke.
    Jood K, Ladenvall P, Tjärnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, Blomstrand C, Jern C.
    Stroke; 2005 Oct 04; 36(10):2077-81. PubMed ID: 16179568
    [Abstract] [Full Text] [Related]

  • 15. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke.
    Bang CO, Park HK, Ahn MY, Shin HK, Hwang KY, Hong SY.
    Cerebrovasc Dis; 2001 Oct 04; 11(4):294-9. PubMed ID: 11385207
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
    Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY.
    Diabetes Metab; 2009 Jun 04; 35(3):214-9. PubMed ID: 19419896
    [Abstract] [Full Text] [Related]

  • 18. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
    Lin S, Huiya Z, Bo L, Wei W, Yongmei G.
    Endocrine; 2009 Dec 04; 36(3):503-9. PubMed ID: 19856137
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
    Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo D, Celentano E, Panico S, Di Minno G.
    Arterioscler Thromb Vasc Biol; 1997 Oct 04; 17(10):2082-7. PubMed ID: 9351375
    [Abstract] [Full Text] [Related]

  • 20. The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms.
    Moore JH, Smolkin ME, Lamb JM, Brown NJ, Vaughan DE.
    Clin Genet; 2002 Jul 04; 62(1):53-9. PubMed ID: 12123488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.